Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.

Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.

Bladder cancer (BCA) is relatively common and potentially recurrent/progressive disease. It is also costly to detect, treat, and control. Definitive diagnosis is made by examination of urine sediment, imaging, direct visualization (cystoscopy), and invasive biopsy of suspect bladder lesions. There a...

Full description

Bibliographic Details
Main Authors: Herbert M Huttanus, Tommy Vu, Georgi Guruli, Andrew Tracey, William Carswell, Neveen Said, Pang Du, Bing G Parkinson, Giuseppe Orlando, John L Robertson, Ryan S Senger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0237070

Internet

https://doi.org/10.1371/journal.pone.0237070

Similar Items